AMGN vs LGVN · P/E 24, rev $10.05B vs rev $2.4M
Amgen Inc (AMGN) versus Longeveron LLC (LGVN) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Longeveron LLC (LGVN) is a biotechnology company listed on NASDAQ.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported LGVN revenue for 2024-12-31 was $2.4M. Net income was -$16.0M. Revenue was up 237.4% from 2023-12-31 to 2024-12-31. LGVN currently screens at market cap $26.5M.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. LGVN currently screens at market cap $26.5M.
Not investment advice. Open the AMGN and LGVN stock pages for the full models.
Not investment advice.